T. Rowe Price Associates’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $75K | Sell |
45,366
-18,119
| -29% | -$30K | ﹤0.01% | 2947 |
|
|
2025
Q1 | $116K | Buy |
63,485
+1,014
| +2% | +$1.85K | ﹤0.01% | 2788 |
|
|
2024
Q4 | $232K | Buy |
62,471
+23,197
| +59% | +$86.1K | ﹤0.01% | 2607 |
|
|
2024
Q3 | $126K | Buy |
39,274
+7,700
| +24% | +$24.7K | ﹤0.01% | 2776 |
|
|
2024
Q2 | $260K | Buy |
31,574
+1,805
| +6% | +$14.9K | ﹤0.01% | 2489 |
|
|
2024
Q1 | $432K | Buy |
29,769
+1,774
| +6% | +$25.7K | ﹤0.01% | 2266 |
|
|
2023
Q4 | $258K | Buy |
27,995
+5,088
| +22% | +$46.9K | ﹤0.01% | 2438 |
|
|
2023
Q3 | $378K | Sell |
22,907
-7,075
| -24% | -$117K | ﹤0.01% | 2239 |
|
|
2023
Q2 | $190K | Buy |
29,982
+1,005
| +3% | +$6.37K | ﹤0.01% | 2544 |
|
|
2023
Q1 | $99K | Buy |
28,977
+6,600
| +29% | +$22.5K | ﹤0.01% | 2688 |
|
|
2022
Q4 | $129K | Sell |
22,377
-373
| -2% | -$2.15K | ﹤0.01% | 2658 |
|
|
2022
Q3 | $214K | Buy |
22,750
+5,170
| +29% | +$48.6K | ﹤0.01% | 2515 |
|
|
2022
Q2 | $392K | Buy |
17,580
+1,184
| +7% | +$26.4K | ﹤0.01% | 2317 |
|
|
2022
Q1 | $901K | Buy |
16,396
+1,092
| +7% | +$60K | ﹤0.01% | 2050 |
|
|
2021
Q4 | $1.01M | Sell |
15,304
-464
| -3% | -$30.7K | ﹤0.01% | 2033 |
|
|
2021
Q3 | $1.32M | Buy |
15,768
+945
| +6% | +$79.3K | ﹤0.01% | 1899 |
|
|
2021
Q2 | $1.88M | Sell |
14,823
-423
| -3% | -$53.7K | ﹤0.01% | 1759 |
|
|
2021
Q1 | $1.67M | Buy |
15,246
+2,528
| +20% | +$277K | ﹤0.01% | 1800 |
|
|
2020
Q4 | $1.82M | Buy |
12,718
+3,299
| +35% | +$471K | ﹤0.01% | 1673 |
|
|
2020
Q3 | $665K | Sell |
9,419
-1,279
| -12% | -$90.3K | ﹤0.01% | 1974 |
|
|
2020
Q2 | $749K | Buy |
+10,698
| New | +$749K | ﹤0.01% | 1903 |
|
|
2019
Q2 | – | Sell |
-67,379
| Closed | -$1.11M | – | 2536 |
|
|
2019
Q1 | $1.11M | Buy |
67,379
+28,846
| +75% | +$477K | ﹤0.01% | 1793 |
|
|
2018
Q4 | $417K | Sell |
38,533
-153,847
| -80% | -$1.66M | ﹤0.01% | 2140 |
|
|
2018
Q3 | $4.82M | Buy |
+192,380
| New | +$4.82M | ﹤0.01% | 1461 |
|